{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:44:24Z","timestamp":1767962664661,"version":"3.49.0"},"reference-count":0,"publisher":"Portico","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2011.47.11.1708829","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T08:48:04Z","timestamp":1409129284000},"page":"817","source":"Crossref","is-referenced-by-count":7,"title":["Ruxolitinib for the treatment of myelofibrosis"],"prefix":"10.3730","volume":"47","author":[{"family":"Ostojic, A.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Vrhovac, R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Verstovsek, S.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2011]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:26:27Z","timestamp":1685453187000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7dcqzw9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":0,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2011.47.11.1708829","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}